期刊文献+

血管紧张素转换酶抑制剂和血管紧张素Ⅱ受体拮抗剂抑制胃癌血管生成 被引量:1

Effects of angiotensin converting enzyme inhibitors and angiotensin Ⅱ receptor blockers on angiogenesis of gastric cancer in a nude mouse model
原文传递
导出
摘要 目的建立人胃癌裸鼠移植瘤模型,观察血管紧张素转换酶抑制剂(ACEI)及血管紧张素Ⅱ受体拮抗剂(ARB)对胃癌生长和血管生成的影响。方法设立对照组、ACEI组(又分为培哚普利组和卡托普利组)、ARB组(又分为氯沙坦组和缬沙坦组),定期观察各组肿瘤生长情况并测量肿瘤体积,3周后取出肿瘤标本,采用免疫组化测定各组的基质金属蛋白酶7(MMP-7)、血管内皮生长因子(VEGF)的表达和癌周微血管密度(MVD)。结果ACEI组和ARB组移植瘤体积与对照组相比.均明显受到抑制(P〈0.011。ACEI组和ARB组肿瘤组织中的VEGF和MVD与对照组比较,均显著降低(P〈0.05和P〈0.01)。ACEI组对MMP-7的表达具有抑制作用(P〈0.05);而ARB对MMP-7无显著抑制作用。结论ACEI和ARB能明显抑制人胃癌裸鼠移植瘤的生长以及新生血管的形成。 Objective To observe the effects of angiotensin converting enzyme inhibitors (ACEI)and angiotensin Ⅱ receptor blocker (ARB) on tumor growth and angiogenesis in implanted gastric cancer mouse model, and to explore the probable mechanism of ACEI and ARB anticancer effect. Methods Nude mouse model with human gastric cancer was established by subcutaneously inoculating human gastric cancer cell line SGC-7901. One week later, 60 mice were randomly divided into 5 groups: control group, perindopril group, captopril group, losartan group, and valsartan group. These groups respectively received the normal saline, perindopril (2 mg/kg), captopril (5 mg/kg), losartan (50 mg/kg),valsartan (40 mg/kg) by gavage once a day. Twenty-one days after treatment the tumors were removed and the tissues were stained by imnmnohistochemistry method to observe the expression of VEGF, MMP-7 and microvessel density (MVD). Results In all the ACEI and ARB groups, tumor volumes were significantly inhibited and MVD also decreased significantly as compared with control group (all P〈0.01). In captopril and perindopril groups, the expression of VEGF and MMP-7 decreased significantly as compared with control group (all P〈0.05). In losartan and valsartan group, the expressions of VEGF were significantly decreased as compared with control group (all P〈 0.05). The expressions of MMP-7 between ARB groups and control group were not significantly different. Conclusion ACEI and ARB can inhibit the tumor growth in gastric cancer model and suppress the angiogenesis of the tumor.
出处 《中华胃肠外科杂志》 CAS 2008年第6期565-568,共4页 Chinese Journal of Gastrointestinal Surgery
基金 广东省自然科学基金(5001766)
关键词 胃肿瘤 血管内皮生长因子 血管紧张素转换酶抑制剂 血管紧张素Ⅱ受 体拮抗剂 Stomach neoplasms Vascular endothelial growth factor Angiotensin convertingenzyme inhibitors Anglotensin Ⅱ receptor blocker
  • 相关文献

参考文献10

  • 1陶厚权,邹寿椿,赵大建,裘华森.胃癌血管浸润与血管形成及转移关系的研究[J].中华胃肠外科杂志,2001,4(4):254-257. 被引量:2
  • 2Lever AF, Hole DJ, Gillis CR, et al. Do inhibitors of angiotensin-Ⅰ-converting enzyme protect against risk of cancer? Lancet, 1998,352 : 179-184.
  • 3Uemura H, Ishiguro H. Nakaigawa N,et al. Angiotensin Ⅱ receptor blocker shows antiproliferative activity in prostate cancer cells: a possibility of tyrosine kinase inhibitor of growth factor. Mol Cancer Ther, 2003, 2 : 1139-1147.
  • 4Lindberg H, Nielsen D, Jensen BV, et al. Angiotensin converting enzyme inhibitors for cancer treatment? Acta Oncol, 2004,43 : 142-152.
  • 5Weidtler N, Folkman J, Pozza F, et al. Tumor angiogenesis: a new significant and independent prognostic indicator in early-stage breast carcinoma. J Natl Cancer Inst, 1992,84:1875-1887.
  • 6Egami K, Murohara T, Shimada T, et ah Role of host angiotensin Ⅱ type 1 receptor in tumor angiogenesis and growth. J Clin Invest, 2003,112 : 67-75.
  • 7Nouet S, Nahmias C. Signal transduction from the angiotensin Ⅱ AT2 receptor. Trends Endocrinol Metab, 2000,11:1-6. Review.
  • 8Imanishi T, Hano T, Nishio I. Angiotensin Ⅱ potentiates vascular endothelial growth factor-induced proliferation and network formation of endothelial progenitor cells. Hypertens Res, 2004,7: 101-108.
  • 9Yoshiji H, Yoshii J, Ikenaka Y, et al. Suppression of the renin-angiotcnsin system attenuates vascular endothelial growth factor-mediated tumor development and angiogenesis in murine hepatocellular carcinoma cells. Int J Oncol, 2002,20: 1227- 1231.
  • 10Arrieta O, Guevara P, Escobar E, et al. Blockage of angiotensin Ⅱ type I receptor decreases the synthesis of growth factors and induces apoptosis in C6 cultured ceils and C6 rat glioma. Br J Cancer, 2005,92: 1247-1252.

二级参考文献13

  • 1Noguchi Y. Blood vessel invasion in gastric carcinoma. Surgery,1990. 107: 140-148.
  • 2Folkman J, Watson K, Ingber D, et al. Induction of angiogenesis during the transition from hyperplasia to neoplasia. Nature,1989, 339: 58-61.
  • 3Folkman J. What is the evidence that tumors are angiogenesis dependent? J Nail Cancer Inst, 1990. 82: 4-6.
  • 4Kech PJ, Hauser SD, Krivi G, et al. Vascular permeability factor, an endothelial cell mitogen related to PDGF. Science, 1989, 246: 1309-1312.
  • 5Brown LF, Berse B, Jackman RW, et al. Expression of vascular permeability factor (vascular endothelial growth factor) and its receptors in adenocarcinomas of the gastrointestinal tract. Cancer Res, 1993, 53: 4727-4735,
  • 6Kieser A, W, eich HA, Brandner G, et al. Mutant P53 potentiatesprotein kinase C induction of vascular endothelial growth factor expression. Oncogene, 1994, 9:963-969.
  • 7Dameron KM, Volpert OV, Tainsky MA, et al. Control of angiogenesis in fibroblasts by P53 regulation of thrombospondin-1. Science, 1994, 265:1582-1584.
  • 8Weidner N, Folkman J, Pozza F, et al. Tumor angiogenesis. A new significant and independent prognostic indicator in early-stage breast carcinoma. J Natl Cancer Inst, 1992, 84: 1875-1887.
  • 9Maehara Y, Hasuda S, Abe T, et al. Tumor angiogenesis and micrometastasis in bone marrow of patients with early gastric cancer. Clin Cancer Res, 1998, 4: 2129-2134.
  • 10Kang SM, Maeda K, Onoda N, et al. Combined analysis of P53 and vascular endothelial growth factor expression in colorectal carcinoma for determination of tumor vascularity and liver metastasis, Int J Cancer, 1997, 74: 502-507.

共引文献1

同被引文献16

引证文献1

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部